Company profile

Aether Bio company profile

Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2017-01-01

Headquarters

Headquarters
New Lisbon, Wisconsin, United States
Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
9
Total equity funding
$64.4M
Last funding
Series Unknown / $15M / 2025-12-03
Last equity funding
Series Unknown / $15M
Investors
21
Lead investors
4
Founders
1
Articles
9

Founders and investors

Founders

Pavle Jeremic

Lead investors

Artis VenturesNatural CapitalTribe CapitalUnless

Investors

Artis VenturesGaingelsSV AngelTribe CapitalUnless

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.